Cargando...

Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer

Amplification of the ERBB2 oncogene at 17q12 is clinically the most relevant genetic aberration in breast cancer and several studies have linked ERBB2 activation to poor clinical outcome. The development of targeted antibody-based therapy for ERBB2-overexpressing tumors and the possible role of ERBB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kauraniemi, Päivikki, Kuukasjärvi, Tuula, Sauter, Guido, Kallioniemi, Anne
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Investigative Pathology 2003
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1892409/
https://ncbi.nlm.nih.gov/pubmed/14578197
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!